Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic

Prakash Gupta, Rajat Kharbanda, Able Lawrence, Latika Gupta

Open source

DOI
10.1016/j.ejr.2021.06.001
Published
2021-10
Container
The Egyptian Rheumatologist
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejr.2021.06.001,
  title = {Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic},
  author = {Prakash Gupta and Rajat Kharbanda and Able Lawrence and Latika Gupta},
  year = {2021},
  journal = {The Egyptian Rheumatologist},
  doi = {10.1016/j.ejr.2021.06.001},
  url = {https://doi.org/10.1016/j.ejr.2021.06.001}
}

RIS

TY  - JOUR
TI  - Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic
AU  - Prakash Gupta
AU  - Rajat Kharbanda
AU  - Able Lawrence
AU  - Latika Gupta
PY  - 2021
JO  - The Egyptian Rheumatologist
DO  - 10.1016/j.ejr.2021.06.001
UR  - https://doi.org/10.1016/j.ejr.2021.06.001
ER  - 

APA

Gupta, P., Kharbanda, R., Lawrence, A., & Gupta, L. (2021). Systemic flare and cutaneous ulceration following cytomegalovirus infection in a patient with anti-melanoma differentiation-associated protein 5 (MDA5) associated myositis: Diagnostic challenge during the time of coronavirus disease (COVID-19) pandemic. The Egyptian Rheumatologist. https://doi.org/10.1016/j.ejr.2021.06.001

Source records